Jia Xiaoyu, Fan Xin, Chen Cheng, Lu Qianyun, Zhou Hongfeng, Zhao Yanming, Wang Xingang, Han Sanyang, Ouyang Liliang, Yan Hongji, Dai Hongliang, Geng Hongya
School of Environmental and Chemical Engineering, Jiangsu University of Science and Technology, Zhenjiang 212018, China.
Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518075, China.
Biomacromolecules. 2024 Feb 12;25(2):564-589. doi: 10.1021/acs.biomac.3c01021. Epub 2024 Jan 4.
As a biodegradable and biocompatible protein derived from collagen, gelatin has been extensively exploited as a fundamental component of biological scaffolds and drug delivery systems for precise medicine. The easily engineered gelatin holds great promise in formulating various delivery systems to protect and enhance the efficacy of drugs for improving the safety and effectiveness of numerous pharmaceuticals. The remarkable biocompatibility and adjustable mechanical properties of gelatin permit the construction of active 3D scaffolds to accelerate the regeneration of injured tissues and organs. In this Review, we delve into diverse strategies for fabricating and functionalizing gelatin-based structures, which are applicable to gene and drug delivery as well as tissue engineering. We emphasized the advantages of various gelatin derivatives, including methacryloyl gelatin, polyethylene glycol-modified gelatin, thiolated gelatin, and alendronate-modified gelatin. These derivatives exhibit excellent physicochemical and biological properties, allowing the fabrication of tailor-made structures for biomedical applications. Additionally, we explored the latest developments in the modulation of their physicochemical properties by combining additive materials and manufacturing platforms, outlining the design of multifunctional gelatin-based micro-, nano-, and macrostructures. While discussing the current limitations, we also addressed the challenges that need to be overcome for clinical translation, including high manufacturing costs, limited application scenarios, and potential immunogenicity. This Review provides insight into how the structural and chemical engineering of gelatin can be leveraged to pave the way for significant advancements in biomedical applications and the improvement of patient outcomes.
作为一种源自胶原蛋白的可生物降解且具有生物相容性的蛋白质,明胶已被广泛用作生物支架和药物递送系统的基本成分,用于精准医学。易于改造的明胶在构建各种递送系统以保护和提高药物疗效从而改善众多药物的安全性和有效性方面具有巨大潜力。明胶卓越的生物相容性和可调节的机械性能允许构建活性三维支架以加速受损组织和器官的再生。在本综述中,我们深入探讨了制备基于明胶的结构并使其功能化的各种策略,这些策略适用于基因和药物递送以及组织工程。我们强调了各种明胶衍生物的优势,包括甲基丙烯酰化明胶、聚乙二醇修饰的明胶、硫醇化明胶和阿仑膦酸盐修饰的明胶。这些衍生物表现出优异的物理化学和生物学性质,能够制造用于生物医学应用的定制结构。此外,我们探索了通过结合添加剂材料和制造平台来调节其物理化学性质的最新进展,概述了基于明胶的多功能微结构、纳米结构和宏观结构的设计。在讨论当前局限性的同时,我们还阐述了临床转化需要克服的挑战,包括高制造成本、有限的应用场景和潜在的免疫原性。本综述深入探讨了如何利用明胶的结构和化学工程为生物医学应用的重大进展以及改善患者预后铺平道路。